Efficacy and Safety of Inhaled Nitric Oxide (NO) in Cystic Fibrosis (CF) Patients

PHASE2TerminatedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

February 22, 2017

Primary Completion Date

June 1, 2020

Study Completion Date

June 1, 2020

Conditions
Cystic Fibrosis
Interventions
DRUG

Nitric Oxide 160 ppm

Nitric Oxide 160 ppm

Trial Locations (7)

29403

Medical University of South Carolina (Site No. 200), Charleston

43205

Nationwide Children's Hospital (Adults can be treated here) (Site No. 600), Columbus

53226

Medical College of Wisconsin (Site No. 400), Milwaukee

90027

Children's Hospital of Los Angeles (Adults can be treated here) (Site No. 500), Los Angeles

92841

* Entire USA* The sponsor will provide air transportation and housing to patients that are not located in the area of clinical trial sites. All trial sites can treat adults., Garden Grove

98195

University of Washington Medical Center (Site No. 100), Seattle

V6Z 1Y6

University of British Columbia, St. Paul's Hospital (Site No. 300), Vancouver

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

collaborator

Mallinckrodt

INDUSTRY

lead

Novoteris, LLC

INDUSTRY